Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Mar;9(1):39-41.
doi: 10.1556/1646.9.2017.1.02.

Nanotechnology: Advancing the translational respiratory research

Kamal Dua  1   2   3 , Shakti Dhar Shukla  2   3 , Terezinha de Jesus Andreoli Pinto  4 , Philip Michael Hansbro  2   3
Affiliations

Nanotechnology: Advancing the translational respiratory research

Kamal Dua et al. Interv Med Appl Sci. 2017 Mar.

Abstract

Considering the various limitations associated with the conventional dosage forms, nanotechnology is gaining increased attention in drug delivery particularly in respiratory medicine and research because of its advantages like targeting effects, improved pharmacotherapy, and patient compliance. This paper provides a quick snapshot about the recent trends and applications of nanotechnology to various translational and formulation scientists working on various respiratory diseases, which can help paving a new path in developing effective drug delivery system.

Keywords: drug delivery; nanoparticulate; nanotechnology; respiratory; translational.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

References

    1. WHO (2014): The Top 10 Causes of Death. Retrieved from http://www.who.int/mediacentre/factsheets/fs310/en/index4.html
    1. Burney P, Jarvis D, Perez-Padilla R: The global burden of chronic respiratory disease in adults. Int J Tuberc Lung Dis 19, 10–20 (2015) - PubMed
    1. Awasthi R, Pant I, Kulkarni GT, Satiko Kikuchi I, de Jesus Andreoli Pinto T, Dua K, Ramana Malipeddi V: Opportunities and challenges in nano-structure mediated drug delivery: Where do we stand? Current Nanomed 6 (2), 78–104 (2016)
    1. Pison U, Welte T, Giersig M, Groneberg DA: Nanomedicine for respiratory diseases. Eur J Pharmacol 533, 341–350 (2006) - PubMed
    1. Mansour HM, Rhee Y-S, Wu X: Nanomedicine in pulmonary delivery. Int J Nanomed 4, 299–319 (2009) - PMC - PubMed

LinkOut - more resources